First Turn Management »

Ascendis Pharma AS shares owned by First Turn Management

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by First Turn Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $28M 105k 266.72

More positions owned by First Turn Management

Revolution Medicines (RVMD)
Abivax Sa Sponsored Ads (ABVX)
Axsome Therapeutics (AXSM)
Enliven Therapeutics (ELVN)
Bridgebio Pharma (BBIO)
Roivant Sciences SHS (ROIV)
United Therapeutics Corporation (UTHR)
Cytokinetics Com New (CYTK)
Xenon Pharmaceuticals (XENE)
Celcuity (CELC)
Miragen Therapeutics (VRDN)
Insmed Com Par $.01 (INSM)
Uniqure Nv SHS (QURE)
Ascendis Pharma A/s Ord Shs (ASND)
Praxis Precision Medicines I Com New (PRAX)

View all positions for First Turn Management

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS